相关产品推荐更多 >

CD103 Antibody, anti-human, PE-Vio® 615, REAfinity™, 30 tests in 60 µL
询价
α-Actinin (Sarcomeric) Antibody, anti-human/mouse/rat, FITC, REAfinity™, 30 tests in 60 µL
询价
CD271 (LNGFR) Antibody, anti-human, PE, 30 tests in 60 µL
询价
CD8 Antibody, anti-human, PE-Vio® 670, REAfinity™, 30 tests in 60 µL
询价
CD10 Antibody, anti-human, pure, 100 µg in 100 µL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
CD165
- 亚型:
recombinant human IgG1
- 形态:
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件:
避光,4-8℃
- 克隆性:
REA1199
- 标记物:
PE
- 适应物种:
human
- 保质期:
24个月
- 供应商:
Miltenyi Biotec
- 宿主:
human cell line
- 应用范围:
Flow cytometry
- 浓度:
1:50
- 抗体英文名:
CD165 Antibody, anti-human, REAfinity™
- 抗体名:
CD165 Antibody, anti-human, REAfinity™
- 规格:
30 tests in 60 µL
Identification and enumeration of CD165+ cells by flow cytometryClone REA1199 recognizes the human CD165 antigen, also known as AD2, which is 37–42 kDa cell surface glycoprotein expressed on most thymocytes, thymic epithelial cells, most platelets, fibroblasts, acute T-lymphoblastic leukemia cells (T-ALL cells), central nervous system neurons, islet cells of the pancreas, and Bowman´s capsule of the kidney. CD165, which is similar to TALLA-1 (CD231, T-cell acute lymphoblastic leukemia antigen), plays a role in cell adhesion between thymocytes and thymic epithelial cells during development. | Additional information: Clone REA1199 displays negligible binding to Fc receptors.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Seon, B. K. (1995) Similarity of TALLA-1, a T-cell acute lymphoblastic leukemia antigen, to GP37. Int. J. Cancer 63 (3): 474. | Takagi, S. et al. (1995) Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily. Int. J. Cancer 61 (5): 706–715.
技术资料暂无技术资料 索取技术资料
文献支持
CD165 Antibody, anti-human, PE, REAfinity™, 30 tests in 60 µL
询价





